| Literature DB >> 16478692 |
Bert A 't Hart1, Paul Smith, Sandra Amor, Gustav J Strijkers, Erwin L A Blezer.
Abstract
Multiple sclerosis is a serious neurological disease that affects 1 in 1000 young adults in Europe and the USA. The development of an effective therapy for this enigmatic disease is plagued by the failure of many treatments to reproduce in patients the promising effects observed in animal models. This review describes a new preclinical model in a non-human primate that might help to bridge the gap between currently used animal models and the patients.Entities:
Mesh:
Year: 2006 PMID: 16478692 DOI: 10.1016/S1359-6446(05)03673-1
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851